What This Immunome Sale Signals Ahead of FDA Milestone
When a biotech firm nears a major FDA decision, every insider transaction can feel like a tell. This article dives in...
Flexible budgeting adapts to life changes, helping you reallocate resources without derailing your overall plans and savings targets.
21,189 articlesWhen a biotech firm nears a major FDA decision, every insider transaction can feel like a tell. This article dives in...
AI-driven capital spending is set to surge, pushing capex crosses trillion next. Here are two industrial stocks—Verti...
Small-cap growth has propelled some funds to the top this year. Discover the overlooked Vanguard outpacing this rally...
A large hedge fund reduced its stake in InterDigital (IDCC) by selling 125,230 shares, worth about $44.28 million. Th...
With prediction markets signaling a modest chance of beating estimates, Beyond Meat investors are weighing whether th...
RxSight's Q4 2025 earnings report could set the tone for its 2026 trajectory. This guide breaks down the key numbers,...
U.S. M2 hit a fresh high in January 2026, but Bitcoin hasn’t followed the traditional liquidity playbook. Here’s what...
The SEC is moving to settle Justin Sun's case with a $10 million penalty, a move that could reshape crypto enforcemen...
A rumored alliance between AMD and Meta Platforms could reshape AI hardware and software ecosystems. This article exa...
A rapidly rising AI infrastructure player has netted multi-billion deals with tech giants and plans for 2026 growth. ...
Warren Buffett's Berkshire Hathaway shows the power of patient capital and simple, durable franchises. This article b...
As Schwab prepares to report Q4 2025 results, investors want clarity on what drives earnings and where risks lie. Thi...